Communicating about comparative effectiveness research: A health affairs symposium on the issues

Health Affairs

Volumn 31, Issue 10, 2012, Pages 2183-2187

  Dentzer, Susan ^a  

^a Health Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOETHICS; CHRONIC DISEASE; COMPARATIVE EFFECTIVENESS; DISABILITY; DRUG COST; DRUG INDUSTRY; FOOD AND DRUG ADMINISTRATION; HEADACHE; HEALTH CARE POLICY; HEALTH INSURANCE; HUMAN; LAW; MEDICAL EDUCATION; MIGRAINE; PRESCRIPTION;

COMMUNICATION; COMPARATIVE EFFECTIVENESS RESEARCH; DRUG APPROVAL; HUMANS; MIGRAINE DISORDERS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84871977084     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2012.0607     Document Type: Article

References (13)

1. New era of comparative effectiveness research (October 2010 special issue). Health Aff (Millwood). 2010; 29(10).
2. Dentzer S. The researcher-in-chief at the Patient-Centered Outcomes Research Institute. Health Aff (Millwood). 2011;30(12):2252-8.
3. Griffin J, Godfrey B, Sherman R. Regulatory requirements of the Food and Drug Administration would preclude product claims based on observational research. Health Aff (Millwood). 2012;31(10):2188-92.
4. People & Places: How can policy protect public health and still foster innovation? Health Aff (Millwood). 2012;31(10):2241.
5. Lipton RB, Stewart WF, Diamond S, Diamond M, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-57.
6. Migraine Research Foundation. Migraine fact sheet [Internet]. New York (NY): The Foundation; [cited 2012 Sep 17]. Available from: http://www.migraineresearchfoundation.org/fact-sheet.html
7. Woolf V. In: Nicolson N, Trautmann J, editors. The letters of Virginia Woolf, vol. 4: 1929-1931. San Diego (CA): Harcourt Brace Jovanovich; 1979. p. 78.
8. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd ed. Cephalalgia. 2004;24(Suppl 1): 9-160.
9. Natoli J, Manack A, Dean B, Butler Q, Turkel C, Stovner L, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia. 2010;30:599-609.
10. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86-92.
11. Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache. 2008;48(4):553-63.
12. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159(8):813-8.
13. Hawkins K, Wang S, Rupnow M. Indirect cost burden of migraine in the United States. J Occup Environ Med. 2007;49:368-74. October